IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology.

The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today.

IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,600 people worldwide.

IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).